PDL BioPharma Inc (NASDAQ:PDLI)

2.90
Delayed Data
As of Apr 20
 0.00 / 0.00%
Today’s Change
2.01
Today|||52-Week Range
3.55
+5.84%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues45.4M143.8M62.7M68.0M
 
 
 
 
 
Cost of Goods Sold2.6M4.5M5.6M17.9M
 
 
 
 
 
Depreciation And Amortization6.0M6.1M6.3M6.3M
 
 
 
 
 
 
Operating ExpensesGross Income36.9M133.2M50.9M43.9M
 
 
 
 
 
General Expenses16.9M19.2M17.6M17.0M
 
 
 
 
 
Research And Development1.8M4.3M605.0K729.0K
 
 
 
 
 
Total Operating Expenses25.5M29.8M29.4M41.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income19.9M114.0M33.3M26.9M
 
 
 
 
 
Extraordinary Credit0.00----3.0M
 
 
Extraordinary Charge-1.4M-1.2M-700.0K0.00
 
 
 
 
Interest Expense On Debt5.0M5.0M5.1M5.1M
 
 
 
 
 
Other Expenses212.0K6.5M-2.0M6.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income13.7M114.3M25.5M31.0M
 
 
 
 
 
Income Taxes-6.6M-53.9M-4.8M-8.6M
 
 
 
 
 
Minority Interest-47.0K0.000.000.00
 
 
Net Income7.2M60.4M20.7M22.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS163.7M155.7M151.1M151.2M
 
 
 
 
 
Shares To Calculate EPS Diluted164.0M156.4M152.3M152.6M
 
 
 
 
 
 
Earnings Per ShareEPS$0.04$0.39$0.14$0.15
 
 
 
 
 
EPS Diluted$0.04$0.39$0.14$0.15